Nykode Therapeutics (NYKD)

Last close As at 09/10/2025

NOK1.74

0.02 (0.99%)

Market capitalisation

NOK562m

Nykode Therapeutics is an Oslo-based clinical-stage biopharmaceutical platform company dedicated to the discovery of novel immunotherapies. Nykode’s vision is to become a leading immunotherapy company, developing therapeutics across a range of areas with high unmet medical need, such as cancers and autoimmune diseases.

Latest Insights

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash, CFA

Director, healthcare

Thematics

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free